Apical hypertrophic cardiomyopathy: clinical follow-up and diagnostic correlates

Division of Cardiology, Toronto General Hospital, Ontario, Canada.

To determine the clinical course of apical hypertrophic cardiomyopathy, 26 patients (mean age 45 years) with asymmetric apical hypertrophy diagnosed by echocardiography or angiography were followed up for an average of 7.3 years (range 1 to 22). Presenting symptoms included atypical chest pain (n = 10), typical angina (n = 6), dyspnea (n = 5) and palpitation (n = 8). Ten patients were asymptomatic. At follow-up all patients had inverted precordial T waves, and 14 had the syndrome of "giant T wave negativity" (greater than or equal to 10 mm). In six patients with electrocardiographic follow-up of greater than 10 years (mean 13.4), precordial T wave inversion had progressed from -0.8 +/- 3.9 to -11.2 +/- 8.0 mm in lead V4 in association with increased QRS amplitude. Episodic atrial fibrillation occurred in 4 of 10 patients with echocardiographic left atrial enlargement. Although left ventricular systolic function was normal, diastolic relaxation was impaired in comparison with values in 10 healthy control subjects: in all 18 patients studied peak filling rate was decreased (4.44 +/- 0.44 versus 6.13 +/- 1.54 stroke volumes/s); time to peak filling was increased (174 +/- 40 versus 147 +/- 32 ms); and atrial systolic contribution to ventricular end-diastolic volume was increased (21.5 +/- 6.8 versus 11.5 +/- 4.6 stroke volume %). During follow-up, 21 of the 26 patients remained in stable condition or were asymptomatic. One patient with normal coronary arteries had an apical myocardial infarction with development of a discrete apical aneurysm and loss of "giant T wave negativity." This patient was the only one to have documented life-threatening ventricular arrhythmias.(ABSTRACT TRUNCATED AT 250 WORDS)

This article has been cited by other articles:

				E. J. Chun, S. I. Choi, K. N. Jin, H. J. Kwag, Y. J. Kim, B. W. Choi, W. Lee, and J. H. Park Hypertrophic Cardiomyopathy: Assessment with MR Imaging and Multidetector CT RadioGraphics, September 1, 2010; 30(5): 1309 - 1328. [Abstract] [Full Text] [PDF]

				H. V. Schaff, M. L. Brown, J. A. Dearani, M. D. Abel, S. R. Ommen, P. Sorajja, A. J. Tajik, and R. A. Nishimura Apical myectomy: A new surgical technique for management of severely symptomatic patients with apical hypertrophic cardiomyopathy J. Thorac. Cardiovasc. Surg., March 1, 2010; 139(3): 634 - 640. [Abstract] [Full Text] [PDF]

				M. S. Maron, J. J. Finley, J. M. Bos, T. H. Hauser, W. J. Manning, T. S. Haas, J. R. Lesser, J. E. Udelson, M. J. Ackerman, and B. J. Maron Prevalence, Clinical Significance, and Natural History of Left Ventricular Apical Aneurysms in Hypertrophic Cardiomyopathy Circulation, October 7, 2008; 118(15): 1541 - 1549. [Abstract] [Full Text] [PDF]

				A. Nasermoaddeli, K. Miura, A. Matsumori, Y. Soyama, Y. Morikawa, A. Kitabatake, Y. Inaba, and H. Nakagawa Prognosis and prognostic factors in patients with hypertrophic cardiomyopathy in Japan: results from a nationwide study Heart, June 1, 2007; 93(6): 711 - 715. [Abstract] [Full Text] [PDF]

				O. Alyan, O. Ozeke, and Z. Golbasi Coronary artery-left ventricular fistulae associated with apical hypertrophic cardiomyopathy Eur Heart J Cardiovasc Imaging, August 1, 2006; 7(4): 326 - 329. [Abstract] [Full Text] [PDF]

				C.E. Chee, C.P. Anastassiades, A.G. Antonopoulos, A.A. Petsas, and L.C. Anastassiades Cardiac hypertrophy and how it may break an athlete's heart - the Cypriot case Eur Heart J Cardiovasc Imaging, August 1, 2005; 6(4): 301 - 307. [Abstract] [Full Text] [PDF]

				J C C Moon, N G Fisher, W J McKenna, and D J Pennell Detection of apical hypertrophic cardiomyopathy by cardiovascular magnetic resonance in patients with non-diagnostic echocardiography Heart, June 1, 2004; 90(6): 645 - 649. [Abstract] [Full Text] [PDF]

				A patient with recurrent syncope Postgrad. Med. J., February 1, 2004; 80(940): 120 - 121. [Full Text] [PDF]

				K. Matsubara, T. Nakamura, T. Kuribayashi, A. Azuma, and M. Nakagawa Sustained cavity obliteration and apical aneurysm formation in apical hypertrophic cardiomyopathy J. Am. Coll. Cardiol., July 16, 2003; 42(2): 288 - 295. [Abstract] [Full Text] [PDF]

				H. Rakowski, M. J. Eriksson, and E. D. Wigle Reply J. Am. Coll. Cardiol., August 21, 2002; 40(4): 838 - 838. [Full Text] [PDF]

				B. J. Maron Hypertrophic Cardiomyopathy: A Systematic Review JAMA, March 13, 2002; 287(10): 1308 - 1320. [Abstract] [Full Text] [PDF]

				M. J. Eriksson, B. Sonnenberg, A. Woo, P. Rakowski, T. G. Parker, E. D. Wigle, and H. Rakowski Long-term outcome in patients with apical hypertrophic cardiomyopathy J. Am. Coll. Cardiol., February 20, 2002; 39(4): 638 - 645. [Abstract] [Full Text] [PDF]

				E D. Wigle CARDIOMYOPATHY: The diagnosis of hypertrophic cardiomyopathy Heart, December 1, 2001; 86(6): 709 - 714. [Full Text] [PDF]

				R. HALL Heart in the 21st century Heart, January 1, 2000; 83(1): 1 - 2. [Full Text] [PDF]

				J.-I. Suzuki, R. Shimamoto, J.-I. Nishikawa, T. Yamazaki, T. Tsuji, F. Nakamura, W. S. Shin, T. Nakajima, T. Toyo-Oka, and K. Ohotomo Morphological onset and early diagnosis in apical hypertrophic cardiomyopathy: a long term analysis with nuclear magnetic resonance imaging J. Am. Coll. Cardiol., January 1, 1999; 33(1): 146 - 151. [Abstract] [Full Text] [PDF]

				E. D. Wigle, H. Rakowski, B. P. Kimball, and W. G. Williams Hypertrophic Cardiomyopathy : Clinical Spectrum and Treatment Circulation, October 1, 1995; 92(7): 1680 - 1692. [Full Text]

				Y.-T. Tai, P.-C. Fong, and W.-H. Chow Bilateral Coronary-Artery-to-Pulmonary-Artery Fistula Coexistent with Apical Hypertrophic Cardiomyopathy A Case Report Angiology, January 1, 1992; 43(1): 72 - 75. [Abstract] [PDF]